Thermo Fisher Scientific (TMO) Long-Term Debt Issuances (2009 - 2026)

Thermo Fisher Scientific has disclosed Long-Term Debt Issuances across 18 years of filings, most recently posting $5.2 billion for Q1 2026.

• Quarterly Long-Term Debt Issuances rose 84.44% year-over-year to $5.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.2 billion (up 257.77% YoY) and the FY2025 annual result came in at $7.8 billion, up 544.44% from the prior year.
• Long-Term Debt Issuances grew to $5.2 billion in Q1 2026, from $4.9 billion in the prior quarter.
• Over five years, Long-Term Debt Issuances peaked at $5.2 billion in Q1 2026 and troughed at -$1.0 million in Q2 2024.
• A 5-year average of $2.9 billion and a median of $3.0 billion in 2022 frame the typical range for Long-Term Debt Issuances.
• Annual changes were most pronounced in 2022 — Long-Term Debt Issuances slumped 78.73% — and 2025, when it surged 135.68%.
• Tracing TMO's Long-Term Debt Issuances over 5 years: stood at $3.2 billion in 2022, then dropped by 22.46% to $2.5 billion in 2023, then plunged by 100.04% to -$1.0 million in 2024, then jumped by 492000.0% to $4.9 billion in 2025, then climbed by 6.49% to $5.2 billion in 2026.
• Business Quant data shows TMO's Long-Term Debt Issuances at $5.2 billion in Q1 2026, $4.9 billion in Q4 2025, and $2.8 billion in Q1 2025.